Schuylkill Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Schuylkill Financial's IHE Position: Q3 2026 in Review
Schuylkill Financial reduced its iShares US Pharmaceuticals ETF (IHE) stake by 2.5% in Q3 2026, selling an estimated $25.4K and leaving 9,770 shares worth $982K. The position accounts for 0.96% of the portfolio, ranked #26.
Schuylkill Financial first reported a position in IHE in Q2 2026 and has held it in 2 quarters since. The position peaked at $992K in Q2 2026. 248 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Schuylkill Financial held 9,770 shares of iShares US Pharmaceuticals ETF worth $982K as of Q3 2026.
- Schuylkill Financial sold 248 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $25.4K.
- iShares US Pharmaceuticals ETF made up 0.96% of Schuylkill Financial's portfolio in Q3 2026, its #26 holding.
- Schuylkill Financial first reported a position in iShares US Pharmaceuticals ETF in Q2 2026 and has held it in 2 quarters since.
- Schuylkill Financial's iShares US Pharmaceuticals ETF position peaked at $992K in Q2 2026.
- 248 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Schuylkill Financial's 13F filing for Q3 2026, filed 21 Oct 2026.